Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.04 USD
Change Today -0.0019 / -4.63%
Volume 611.7K
As of 8:10 PM 04/24/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Katherine Stueland

Former Vice President of Corporate Communications and Vice President of Investor Relations, Dendreon Corp.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 2 different industries.

----

Background*

Ms. Katherine Stueland served as an Associate of WeissComm Partners, Inc. Ms. Stueland served as Vice President of Corporate Communications and Investor Relations at Dendreon Corp. Ms. Stueland joined WeissComm from TAP Pharmaceutical Products Inc., where she served as the Head of Public Affairs and was responsible for providing strategic counsel to the executive leadership team and managing product and marketing public relations for Prevacid for acid reflux and Lupron ...

Read Full Background

Corporate Headquarters*

1301 2nd Avenue
Seattle, Washington 98101

United States

Phone: 206-256-4545
Fax: 206-256-0571

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

Unknown/Other Education
Miami University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DNDNQ:US $0.04 USD -0.0019

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
David P. King Chairman and Chief Executive Officer
Laboratory Corp. of America Holdings
$1.0M
Peter D. Meldrum Ph.D.Chief Executive Officer, President and Director
Myriad Genetics Inc.
$997.0K
Stephen H. Rusckowski Chief Executive Officer, President, Director and Member of Executive Committee
Quest Diagnostics Inc.
$1.1M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DENDREON CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.